Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,164 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03847649RecruitingPhase 2
Durvalumab for cancer after stopping immune therapy due to side effects
This Phase 2 trial tests whether durvalumab (an immunotherapy) can still help treat advanced cancer after you had to stop an earlier immune checkpoint medicine because of immune-related side effects. If you’re already on a durvalumab-based study, Substudy B also looks at continuing durvalumab (with or without tremelimumab) when it’s safe for you.
Edmonton, AlbertaAges 18 years+ - NCT03729180Recruiting
Using genetic test results to guide care during surgery
This study looks at whether using a person’s genetic information helps doctors make better decisions during planned surgery. It may help tailor care, but you would only join if you can consent and don’t have certain serious conditions.
Chicago, IllinoisAges 18 years+ - NCT03628612Enrolling by invitationPhase 2
Long-term follow-up after CAR T cell treatment
This study checks how people do over the long run after receiving a personalized, genetically modified CAR T cell treatment. It may help researchers understand long-term safety and outcomes, which can improve future care.
Miami, FloridaAges 1 year+ - NCT03516617RecruitingPhase 2
Acalabrutinib with or without obinutuzumab for early CLL/SLL
This Phase 2 trial studies whether acalabrutinib, and optionally adding obinutuzumab, can control early-stage chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It aims to see how well these treatments work and how safe they are in people who have not had prior treatment.
Scottsdale, ArizonaAges 18 years+ - NCT03415620Recruiting
Music listening during surgery to reduce anxiety and pain
This study tests whether listening to music around the time of surgery can lower anxiety and pain, reduce how much pain medicine you need, and improve satisfaction. You may be asked to fill out brief questionnaires before and after your procedure.
SingaporeAges 21–70 - NCT03308773Enrolling by invitation
Prevention program for people at risk of type 2 diabetes
This trial looks at a personalized prevention approach for people who are at risk of developing type 2 diabetes. It may help by targeting your specific health factors before diabetes starts.
Ages 18–100 - NCT03049072Recruiting
Registry for people treated with ion beam therapy at MedAustron
This trial is a patient registry that collects information from people treated with ion beam therapy at MedAustron. It helps researchers understand treatment patterns and outcomes and may improve care for future patients.
Wiener Neustadt, Lower AustriaAges Any age - NCT03115203Recruiting
MRI muscle imaging study for facial paralysis
This study uses a stronger MRI machine (3 Tesla) to take detailed pictures of skin and face muscles in people with facial paralysis. It may help doctors better understand what changes happen in the face muscles over time.
Amiens, PicardieAges 18 years+ - NCT03058185Recruiting
Study of people with LMNA or EMD gene mutations
This study follows people who have a confirmed harmful (pathogenic) mutation in the LMNA and/or EMD gene. It aims to better understand these conditions through regular follow-up and health information collection, which may help improve future care.
Angers, AngersAges Any age - NCT02333110Recruiting
Grid radiation therapy for advanced, painful tumors
This trial tests a way of giving palliative radiation using a “grid” to treat advanced tumors that are large, resistant to standard radiation, or already needed more than one palliative radiation session. It may help better control symptoms when a cure is not the goal.
Montreal, QuebecAges 18 years+ - NCT02416388RecruitingPhase 2/Phase 3
Trial for AML treatments and preventing graft-versus-host disease
This trial tests different chemotherapy induction, consolidation (follow-up treatment), and strategies to prevent complications after an allogeneic stem cell transplant. It aims to improve overall survival and reduce serious transplant side effects like graft-versus-host disease (GVHD).
AmiensAges 18–61 - NCT02445222RecruitingPhase 3
Follow-up study for people treated with CAR-T therapy
This study checks how people do over the long term after receiving CAR-T, an advanced immune treatment. It may help doctors understand long-term safety and benefits, and what to expect after treatment.
Phoenix, ArizonaAges birth–100 years - NCT01696721Recruiting
Pediatric radiation therapy registry for children under 22
This study is a registry that collects information from children and teens who receive radiation therapy at participating hospitals. It helps researchers learn how radiation is used in pediatrics and may improve future care.
Palo Alto, CaliforniaAges Up to 21 years - NCT01280825Recruiting
Testing how to use genetic medicine results in routine care
This study looks at how to put genetic testing results (pharmacogenomics) into regular doctor care. It aims to see whether using the results helps doctors choose safer, better-matched medications.
Chicago, IllinoisAges 18 years+ - NCT07880977Recruiting
Shenfu injection for preventing ventilator dependence
This trial tests whether a traditional Chinese medicine called Shenfu injection can help people on breathing machines get off them sooner. If you are on a ventilator, this treatment might reduce the chance of becoming dependent on it.
Yiwu, ZhejiangAges 19–75 - NCT01306019RecruitingPhase 1/Phase 2
Gene therapy for severe combined immunodeficiency in older children and adults
This trial tests a one-time gene therapy that aims to fix the genetic problem causing X-linked severe combined immunodeficiency (XSCID). It is for people aged 2 to 50 who lack a matched sibling donor and have persistent immune problems.
Bethesda, MarylandAges 2–50 - NCT07880067Recruiting
Surgery's effect on mouth weakness and swallowing in sleep apnea
This study looks at how surgery for obstructive sleep apnea (a condition where breathing stops during sleep) affects mouth strength and swallowing. It may help patients understand if surgery can improve these functions.
Kaohsiung CityAges 20 years+ - NCT07881588Recruiting
Diabetes foot artery risk prediction study
This study aims to build a tool that predicts the risk of developing blocked arteries in the legs (a condition called arteriosclerosis obliterans) in people with type 2 diabetes. By identifying risks early, patients can take steps to prevent serious complications.
Nanchang, Jang XIAges 18 years+ - NCT07879976Recruiting
Feelings and emotions in teens with epilepsy
This study looks at how teenagers with certain types of epilepsy understand and manage their emotions. It may help doctors better support young people with epilepsy.
AlessandriaAges 10–18 - NCT07881172Recruiting
Neuroblastoma genetic study for children and young adults
This study looks at the genetic and biological details of neuroblastoma tumors to better understand the disease. It may help find better treatments in the future.
AnconaAges birth–31 years - NCT07701096Recruiting
Home breathing support monitoring for advanced COPD
This study tests a home monitoring system that watches how well noninvasive breathing support (a mask that helps you breathe) works for people with severe COPD. The system sends early warnings to your care team if your breathing patterns change, which may help prevent flare-ups.
BeijingAges 18 years+ - NCT07716449RecruitingPhase 3
Immunotherapy combo for stomach or esophagus cancer
This trial tests a new immunotherapy drug (QLS31905) combined with standard chemotherapy for people with advanced stomach or gastroesophageal junction cancer who have not had prior treatment. It aims to see if this new combination works better than the current standard treatment.
BeijingAges 18 years+ - NCT07501494Recruiting
How intensive care quality affects patient outcomes
This study looks at how the quality of intensive care affects patient outcomes and costs. By reviewing existing data, researchers hope to find ways to improve care for future patients.
BerlinAges 18 years+ - NCT06085716RecruitingPhase 2/Phase 3
Combination therapy for cancer-related fatigue
This study tests a combination of treatments to help reduce fatigue in people with advanced cancer. If you have been feeling very tired for at least two weeks, this trial might offer new ways to improve your energy.
Houston, TexasAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,164 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.